CN102838639A - Synthetic method of N-aryl-D-glucosamine - Google Patents

Synthetic method of N-aryl-D-glucosamine Download PDF

Info

Publication number
CN102838639A
CN102838639A CN201210059071XA CN201210059071A CN102838639A CN 102838639 A CN102838639 A CN 102838639A CN 201210059071X A CN201210059071X A CN 201210059071XA CN 201210059071 A CN201210059071 A CN 201210059071A CN 102838639 A CN102838639 A CN 102838639A
Authority
CN
China
Prior art keywords
glucosamine
aryl
tetrabenzyl
compound method
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201210059071XA
Other languages
Chinese (zh)
Inventor
陶传洲
刘玮炜
刘峰
李亚凤
朱佑民
周建
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huaihai Institute of Techology
Original Assignee
Huaihai Institute of Techology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huaihai Institute of Techology filed Critical Huaihai Institute of Techology
Priority to CN201210059071XA priority Critical patent/CN102838639A/en
Publication of CN102838639A publication Critical patent/CN102838639A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention provides a synthetic method of N-aryl-D-glucosamine, comprising the steps of using 1,3,4,6-O-4-benzyl-D-glucosamine hydrochloride as a raw material to synthesize 1,3,4,6-O-4-benzyl-N-aryl-D-glucosamine through C-N cross-coupling reaction under catalysis of copper, and then performing debenzylation to synthesize N-aryl-D-glucosamine. According to the invention, different aryl iodides can be used to synthesize different substituted N-aryl-D-glucosamine, and the method is universal and has high efficiency; and copper which is easily accessible and cheap is used as catalyst, the condition is mild, the yield is high and the method has good application prospect.

Description

A kind of compound method of N-aryl-D-glucosamine
Technical field
The present invention relates to the organic synthesis field, relate in particular to the compound method of N-aryl-D-glucosamine.
Background technology
D-glucosamine (D-Glucosamine) be with crab, shrimp, shell body be raw material through the monose that processing makes, have the synthetic isoreactivity of treatment of arthritis, anti-inflammatory, SP polysaccharide.Contain reactive group amino in the D-glucosamine molecular structure, carry out chemically modified and can obtain different verivates.These modification reactions not only help structure activity study, and in molecule, introduce other group, will find the material that biological activity is stronger.Because the mutual intersection and the infiltration of each subject in recent years makes the chemical modification method of D-glucosamine constantly expand.
At present, the chemically modified in D-glucosamine N site lays particular emphasis on acidifying, acidylate, alkylation, and N-arylation verivate seldom obtains.Up to now, there is two routine N-arylations-D-glucosamine verivate to obtain synthetic ((a) Harton, D. J. Org. Chem. 1964, 29, 1776. (b) Jung, M. E.; Dong, T. A.; Cai, X.-L. Tetrahedron Lett. 2011, 52, 2533.), shown in the following chemical formula:
Figure 709179DEST_PATH_IMAGE001
Use simple nucleophilic substitution synthesizing aryl verivate in the aforesaid method, aromatic yl reagent-ing need be haled electronics base nitro, is difficult to carry out otherwise react, and the method universality is poor, the substrate narrow application range.Therefore, seek that a kind of wide spectrum is suitable for synthetic N-aryl-the D-glucosamine thereof, derivatives thereof is very important.
Summary of the invention
The compound method that the purpose of this invention is to provide a kind of N-aryl-D-glucosamine verivate, with 1,3,4,6-O-tetrabenzyl-D-glucosamine is a raw material, obtains N-aryl-D-glucosamine.
For reaching the foregoing invention purpose, the present invention proposes the compound method of N-aryl-D-glucosamine verivate, and its synthesis path is as follows:
Figure 433509DEST_PATH_IMAGE002
The compound method of N-aryl provided by the invention-D-glucosamine verivate comprises following steps:
S1. with formula ( α) shown in 1,3,4,6-O-tetrabenzyl-D-glucosamine hydrochloride, formula ( β) shown in aryl iodide, cesium carbonate, cuprous salt and 2-acetyl cyclohexanone be dissolved among the DMF, in 120-130 ℃ of following stirring reaction 8-20 hour, postcooling was accomplished in reaction under protection of nitrogen gas; The ether dilution is filtered, and takes out and desolvates; The silica gel chromatography dilution obtains intermediate product, formula ( γ) shown in 1,3,4,6-O-tetrabenzyl-N-aryl-D-glucosamine;
S2. the intermediate product that step S1 is obtained, formula ( γ) shown in 1,3,4,6-O-tetrabenzyl-N-aryl-D-glucosamine is dissolved in methyl alcohol and the ETHYLE ACETATE mixed solvent, adds trichoroacetic acid(TCA) and palladium carbon, feeding H 2, stirred 30-48 hour down in 40 ℃, filter, methanol wash is taken out and is desolvated, silica gel chromatography, finally obtain formula ( δ) shown in N-aryl ammonia-D-base glucose.
In the compound method of above-mentioned N-aryl-D-glucosamine verivate, formula ( β) shown in aryl iodide in R be 3 or the 4-substituting group, substituting group is H, alkyl, alkoxyl group, halogen, COOR1, wherein R1 is an alkyl.
Among the step S1 of aforesaid method, the consumption molar ratio of α (1,3,4,6-O-tetrabenzyl-D-glucosamine hydrochloride) and aryl iodide is n (α): n (aryl iodide)=1.0: 2.0 – 1.0: 3.0.
Among the step S1 of aforesaid method, cuprous salt is CuI, CuBr, CuCl.The consumption molar ratio of α (1,3,4,6-O-tetrabenzyl-D-glucosamine hydrochloride) and cuprous salt is n (α): n (cuprous salt)=1.0: 0.1 – 1.0: 0.2.
Among the step S1 of aforesaid method, the consumption molar ratio of α (1,3,4,6-O-tetrabenzyl-D-glucosamine hydrochloride) and 2-acetyl cyclohexanone is n (α): n (2-acetyl pimelinketone)=1.0: 0.2 – 1.0: 0.4.
Among the step S1 of aforesaid method, 1,3,4 shown in the formula (α), the consumption molar ratio of 6-O-tetrabenzyl-D-glucosamine hydrochloride and cesium carbonate is 1.0: 2.5 – 1.0: 3.0.
Among the step S1 of aforesaid method, α (1,3,4,6-O-tetrabenzyl-D-glucosamine hydrochloride) is n (α): V (DMF)=1.0mmol with the usage ratio of DMF: 0.5mL – 1.0mmol: 0.6mL.
Among the step S2 of aforesaid method, intermediate product β and trichoroacetic acid(TCA) molar ratio are n (β): n (trichoroacetic acid(TCA))=1.0: 1.0 – 1.0: 1.1.
 
Embodiment
To help to understand the present invention through following examples of implementation, but and limit content of the present invention.
1,1,3,4,6-O-tetrabenzyl-D-glucosamine hydrochloride synthetic
Figure 213247DEST_PATH_IMAGE003
(1eq. 100mmol) is dissolved in aqueous sodium hydroxide solution (1eq., the 100mmol of 100mL with the 21.5gD-glucosamine hydrochloride; C=1mol/L), under the vigorous stirring, drip the aubepine (1eq. of 12.1mL in the room temperature; 100mmol), continue to stir 2h, termination reaction.Decompress filter, the washing (2 * 20mL), ether wash (2 * 20mL), vacuum-drying 12h, crude product 2, productive rate 70%.
With 1.48g exsiccant compound 2(1eq., 50mmol), (5eq. 250mmol) is dissolved among the 200mL exsiccant DMF 30mL benzyl bromine, ice-water bath cooling.Under the vigorous stirring, add 10.0g sodium hydride (57%-63% oil content looses, and 250mmol divides 10 equal portions to add).System returns to room temperature, continues to stir 12h, in system, drips 40mL ETHYLE ACETATE termination reaction.Rotary Evaporators revolves dried, and the ether dilution is washed once, the dried over mgso organic layer, and Rotary Evaporators revolves dried, gets crude product 3Silica gel (sherwood oil: triethylamine=100mL:1mL soaks) column chromatography purification (eluent: sherwood oil: ETHYLE ACETATE: triethylamine=25mL: 100mL: 1mL), get yellow oily compound 3, productive rate 85%.
With compound 3Be dissolved in the acetone (50mL), add 10mL hydrochloric acid soln (5N), backflow 30min is cooled to room temperature, suction filtration solid, acetone wash (2 * 10mL), compound αThe methanol aqueous solution recrystallization gets white needle-like crystals, productive rate 75%.m.p.?138℃-140℃,? 1H?NMR?(400?MHz,?DMSO)?δ?8.41?(s,?br,?3H),?7.46?(dd,?J?=?8.1,?1.4?Hz,?2H),?7.41?–?7.25?(m,?16H),?7.19?–?7.13?(m,?2H),?4.89?–?4.77?(m,?4H),?4.69?(d,?J?=?11.7?Hz,?1H),?4.65?(d,?J?=?11.0?Hz,?1H),?4.59?–?4.51?(m,?3H),?3.87?(dd,?J?=?10.3,?8.6?Hz,?1H),?3.76?–?3.56?(m,?4H),?3.09?–?3.02?(m,?1H).?IR?(KBr)?n:?3551,?3474,?3414,?3029,?2923,?1638,?1617,?1499,?1105,?1069,?618。
2,1,3,4,6-O-tetrabenzyl-N-aryl-D-glucosamine synthetic
Figure 670773DEST_PATH_IMAGE004
2.1 1,3,4, the preparation of 6-O-tetrabenzyl-N-phenyl-D-glucosamine
In the Schlenk reaction tubes, add 288mg 1,3,4, and 6-O-tetrabenzyl-D-glucosamine hydrochloride (1eq., 0.5mmol); The 19mg cuprous iodide (20mol%, 0.10mmol) (3eq. 1.5mmol), vacuumizes with the 490mg cesium carbonate; Adding 168uL iodobenzene under the logical nitrogen (3eq., 1.5mmol), the 26uL2-acetyl cyclohexanone (40mol%, 0.20mmol); 0.25mL N, dinethylformamide, the sealed reaction system stirs 16h in 130 ℃ of oil baths.Cooling adds the dilution of 20mL ether, filters, and takes out and desolvates, silica gel column chromatography (ETHYLE ACETATE: the purifying of sherwood oil=1:8), productive rate: 81%.m.p.?114 oC-117 oC.? 1H?NMR?(400?MHz,?DMSO)?δ?7.40?–?7.27?(m,?8H),?7.25?–?7.14?(m,?10H),?7.11?–?7.03?(m,?4H),?6.74?(d,?J?=?7.8?Hz,?2H),?6.54?(t,?J?=?7.0?Hz,?1H),?5.62?(d,?J?=?9.0?Hz,?1H),?4.81?–?4.71?(m,?3H),?4.65?(d,?J?=?10.8?Hz,?1H),?4.61?–?4.51?(m,?4H),?4.48?(d,?J?=?7.9?Hz,?1H),?3.76?–?3.63?(m,?3H),?3.59?–?3.51?(m,?2H),?3.47?–?3.37?(m,?1H).? 13C?NMR?(100?MHz,?DMSO)?δ?149.08,?138.50,?138.32,?138.28,?137.84,?128.64,?128.23,?128.20,?127.98,.127.97,?127.73,?127.70,?127.58,?127.52,?127.42,?127.28,?127.16,?127.01,?115.70,?112.78,?102.56,?84.17,?77.99,?74.13,?74.09,?73.91,?72.36,?70.04,?68.92,?59.66.?IR?(KBr)? n:?3548,?3478,?3414,?1636,?1620,?1111,?1072,?620。
2.2 1,3,4, the preparation of 6-O-tetrabenzyl-N-(4-aminomethyl phenyl)-D-glucosamine
In the Schlenk reaction tubes, add 288mg 1,3,4, and 6-O-tetrabenzyl-D-glucosamine hydrochloride (1eq., 0.5mmol); 218mg to the methyl iodobenzene (2eq., 1.0mmol), the 19mg cuprous iodide (20mol%, 0.10mmol) with 490mg cesium carbonate (3eq.; 1.5mmol), vacuumize, and adding 26uL 2-acetyl cyclohexanone under the logical nitrogen (40mol%, 0.20mmol); 0.26mL N, dinethylformamide, the sealed reaction system stirs 12h in 120 ℃ of oil baths.Cooling adds the dilution of 20mL ether, filters, and takes out and desolvates, silica gel column chromatography (ETHYLE ACETATE: the purifying of sherwood oil=1:8), productive rate: 72%.m.p.?115 oC-116 oC.? 1H?NMR?(400?MHz,?DMSO)?δ?7.39?–?7.27?(m,?8H),?7.25?–?7.16?(m,?10H),?7.14?–?7.07?(m,?2H),?6.89?(d,?J?=?8.2?Hz,?2H),?6.67?(d,?J?=?8.4?Hz,?2H),?4.84?–?4.70?(m,?3H),?4.66?(d,?J?=?10.9?Hz,?1H),?4.62?–?4.51?(m,?4H),?4.48?(d,?J?=?8.0?Hz,?1H),?3.79?–?3.60?(m,?3H),?3.60?–?3.50?(m,?2H),?3.41?–?3.36?(m,?1H),?2.17?(s,?3H).? 13C?NMR?(100?MHz,?DMSO)?δ?146.85,?138.57,?138.33,?138.30,?137.87,?129.09,?128.23,?128.20,?127.97,?127.73,?127.69,?127.58,?127.51,?127.42,?127.28,?127.17,?127.03,?124.11,?113.00,?102.66,?84.19,?78.01,?74.09,?74.07,?73.91,?72.37,?70.05,?68.95,?60.17,?20.08.?IR?(KBr)? n:?3548,?3477,?3417,?1636,?1617,?1565,?1415,?1123,?1111,?1069,?617。
2.3 1,3,4, the preparation of 6-O-tetrabenzyl-N-(4-p-methoxy-phenyl)-D-glucosamine
In the Schlenk reaction tubes, add 288mg 1,3,4, and 6-O-tetrabenzyl-D-glucosamine hydrochloride (1eq., 0.5mmol); 350mg 4-methoxyl group iodobenzene (3eq., 1.5mmol), (20mol% is 0.10mmol) with 456mg cesium carbonate (2.8eq. for the 10mg cuprous chloride; 1.4mmol), vacuumize, and adding 26uL 2-acetyl cyclohexanone under the logical nitrogen (40mol%, 0.20mmol); 0.27mL N, dinethylformamide, the sealed reaction system stirs 8h in 130 ℃ of oil baths.Cooling adds the dilution of 20mL ether, filters, and takes out and desolvates, silica gel column chromatography (ETHYLE ACETATE: the purifying of sherwood oil=1:6), productive rate: 59%.m.p.?107 oC-109 oC.? 1H?NMR?(400?MHz,?DMSO)?δ?7.40?–?7.15?(m,?18H),?7.15?–?7.09?(m,?2H),?6.70?(s,?4H),?4.83?–?4.64?(m,?4H),?4.62?–?4.50?(m,?4H),?4.47?(d,?J?=?8.0?Hz,?1H),?3.79?–?3.59?(m,?6H),?3.54?(d,?J?=?5.2?Hz,?2H),?3.29?(dd,?J?=?9.3,?8.2?Hz,?1H).? 13C?NMR?(100?MHz,?DMSO)?δ?150.77,?143.36,?138.60,?138.33,?138.30,?137.88,?128.24,?128.22,?128.00,?127.99,?127.72,?127.71,?127.60,?127.53,?127.43,?127.30,?127.19,?127.04,?114.38,?113.93,?102.79,?84.23,?78.03,?74.07,?73.90,?72.37,?70,09,?68.95,?60.84,?55.36.?IR?(KBr)? n:?3548,?3474,?3417,?1637,?1618,?1562,?1516,?1451,?1244,?1116,?1070,?742,?694。
2.4 1,3,4, the preparation of 6-O-tetrabenzyl-N-(4-chloro-phenyl-)-D-glucosamine
In the Schlenk reaction tubes, add 288mg 1,3,4, and 6-O-tetrabenzyl-D-glucosamine hydrochloride (1eq., 0.5mmol); 238mg is to chloroiodobenzone (2eq., 1.0 mmol), and (10mol% is 0.05mmol) with 423mg cesium carbonate (2.6eq. for the 10mg cuprous iodide; 1.3mmol), vacuumize, and adding 13uL 2-acetyl cyclohexanone under the logical nitrogen (20mol%, 0.10mmol); 0.28mL N, dinethylformamide, the sealed reaction system stirs 14h in 125 ℃ of oil baths.Cooling adds the dilution of 20mL ether, filters, and takes out and desolvates, silica gel column chromatography (ETHYLE ACETATE: the purifying of sherwood oil=1:6), productive rate: 71%.m.p.?118 oC-120 oC.? 1H?NMR?(400?MHz,?DMSO)?δ?7.39?–?7.27?(m,?8H),?7.24?–?7.15?(m,?8H),?7.16?(dd,?J?=?7.0,?2.5?Hz,?2H),?7.12?–?7.05?(m,?4H),?6.74?(d,?J?=?8.9?Hz,?2H),?4.82?–?4.70?(m,?3H),?4.67?(d,?J?=?10.9?Hz,?1H),?4.60?–?4.52?(m,?4H),?4.47?(d,?J?=?8.1?Hz,?1H),?3.80?–?3.52?(m,?5H),?3.46?–?3.37?(m,?1H).? 13C?NMR?(100?MHz,?DMSO)?δ?148.07,?138.46,?138.32,?138.25,?137.78,?128.30,?128.24,?128.22,?128.00,?127.73,?127.67,?127.60,?127.55,?127.43,?127.34,?127.24,?127.01,?118.85,?114.15,?102.47,?84.01,?78.01,?74.18,?74.10,?73.95,?72.38,?70.11,?68.88,?59.64.?IR?(KBr)? n:?3445,?3343,?3029,?2895,?2862,?1600,?1517,?1492,?1450,?1114,?1070,?995,?813,?749,?697。
2.5 1,3,4, the preparation of 6-O-tetrabenzyl-N-(4-ethoxy acyl group phenyl)-D-glucosamine
In the Schlenk reaction tubes, add 288mg 1,3,4, and 6-O-tetrabenzyl-D-glucosamine hydrochloride (1eq., 0.5mmol); The 12mg cuprous bromide (20mol%, 0.10mmol) (2.5eq. 1.25mmol), vacuumizes with the 408mg cesium carbonate; Adding 250uL 4-Iodobenzoic acid ethyl ester under the logical nitrogen (3eq., 1.5mmol), 26uL 2-acetyl cyclohexanone (40mol%, 0.20mmol); 0.26mL N, dinethylformamide, the sealed reaction system stirs 15h in 130 ℃ of oil baths.Cooling adds the dilution of 20mL ether, filters, and takes out and desolvates, silica gel column chromatography (ETHYLE ACETATE: the purifying of sherwood oil=1:6), productive rate: 63%.m.p.?115 oC-116 oC.? 1H?NMR?(400?MHz,?DMSO)?δ?7.69?(d,?J?=?8.9?Hz,?2H),?7.40?–?7.26?(m,?8H),?7.22?–?7.14?(m,?10H),?7.06?(dd,?J?=?7.4,?2.1?Hz,?2H),?6.77?(d,?J?=?8.9?Hz,?2H),?4.84?–?4.63?(m,?4H),?4.62?–?4.47?(m,?5H),?4.22?(q,?J?=?7.1?Hz,?2H),?3.81?–?3.52?(m,?6H),?1.28?(t,?J?=?7.1?Hz,?3H).? 13C?NMR?(100?MHz,?DMSO)?δ?165.86,?153.15,?138.35,?138.31,?138.21,?137.72,?130.77,?128.25,?128.23,?128.01,?127.99,?127.76,?127.64,?127.61,?127.57,?127.44,?127.35,?127.26,?127.00,?116.33,?111.70,?102.04,?83.71,?77.96,?74.23,?74.14,?73.98,?72.39,?70.05,?68.84,?59.48,?58.69,?14.38.?IR?(KBr)? n:?3468,?3420,?3353,?3029,?2900,?2866,?1700,?1610,?1537,?1274,?1175,?1111,?1069,?752,?694。
2.6 1,3,4, the preparation of 6-O-tetrabenzyl-N-(3-methoxy acyl group phenyl)-D-glucosamine
In the Schlenk reaction tubes, add 288mg 1,3,4,6-O-tetrabenzyl-D-glucosamine hydrochloride (1eq.; 0.5mmol), the 15mg cuprous iodide (16mol%, 0.08mmol) with the 410mg cesium carbonate (2.5eq., 1.25mmol); Vacuumize, and adding 342mg m-iodobenzoic acid methyl esters under the logical nitrogen (2.6eq., 1.3mmol); 26uL 2-acetyl cyclohexanone (40mol%, 0.20mmol), the N of 0.3mL; Dinethylformamide, the sealed reaction system stirs 20h in 130 ℃ of oil baths.Cooling adds the dilution of 20mL ether, filters, and takes out and desolvates, silica gel column chromatography (ETHYLE ACETATE: the purifying of sherwood oil=1:6), productive rate: 54%. 1H?NMR?(400?MHz,?DMSO)?δ?7.42?–?7.25?(m,?10H),?7.23?–?7.12?(m,?11H),?7.12?–?7.06?(m,?2H),?7.02?–?6.95?(m,?1H),?4.85?–?4.64?(m,?4H),?4.62?–?4.46?(m,?5H),?3.86?–?3.50?(m,?9H),?3.44?(t,?J?=?8.7?Hz,?1H).? 13C?NMR?(100?MHz,?DMSO)?δ?166.86,?149.32,?138.48,?138.33,?138.27,?137.79,?130.11,?128.96,?128.28,?128.26,?128.02,?127.99,?127.77,?127.65,?127.59,?127.48,?127.36,?127.22,?126.93,?117.44,?116.59,?115.53,?113.09,?102.58,?83.78,?78.10,?74.27,?74.12,?73.99,?72.42,?70.17,?68.90,?59.61,?51.86.。
3, N-aryl-D-glucosamine is synthetic
Figure 485145DEST_PATH_IMAGE005
3.1 N-phenyl-D-glucosamine is synthetic
With 308mg 1,3,4; (1eq. 0.5mmol) is dissolved in methyl alcohol and ETHYLE ACETATE (4mL+2mL) mixed solvent 6-O-tetrabenzyl-N-phenyl-D-glucosamine, adds 82mg trichoroacetic acid(TCA) (1eq.; 0.5mmol) and 100mg palladium carbon (10%Pd), be heated to 40 ℃, H 2Stirred in the atmosphere 30 hours, and filtered, methanol wash is taken out and is desolvated, silica gel column chromatography (trichloromethane: the purifying of methyl alcohol=8:1), productive rate: 76%. 1H?NMR?(400?MHz,?DMSO),?α?:?β?≈?2.7?:?1,?δ?7.06?(t,?J?=?7.5?Hz,?5.2H),?7.00?(t,?J?=?7.6?Hz,?2H),?6.78?–?6.65?(m,?7.8H),?6.56?(t,?J?=?6.7?Hz,?2.7H),?6.50?(t,?J?=?6.9?Hz,?1H),?5.00?(d,?J?=?2.8?Hz,?2.5H),?4.38?(d,?J?=?8.0?Hz,?1H),?3.82?–?3.41?(m,?40H),?3.24?–?3.10?(m,?4H).?IR?(KBr)?n:?IR?(KBr)?n:?3383,?2975,?2927,?2898,?1644,?1450,?1412,?1382,?1088,?1049,?880,?637。
3.2 N-(4-p-methoxy-phenyl)-D-glucosamine is synthetic
With 323mg 1,3,4; (1eq. 0.5mmol) is dissolved in methyl alcohol and ETHYLE ACETATE (4mL+2mL) mixed solvent 6-O-tetrabenzyl-N-(4-p-methoxy-phenyl)-D-glucosamine, adds 90mg trichoroacetic acid(TCA) (1.1eq.; 0.55mmol) and 100mg palladium carbon (10%Pd), be heated to 40 ℃, H 2Stirred in the atmosphere 48 hours, and filtered, methanol wash is taken out and is desolvated, silica gel column chromatography (trichloromethane: the purifying of methyl alcohol=8:1), productive rate: 87%. 1H?NMR?(400?MHz,?DMSO)?δ?α?:?β?≈?2.8?:?1,?7.36?(t,?J?=?11.1?Hz,?2H),?7.00?(d,?J?=?8.4?Hz,?2H),?4.74?(d,?J?=?2.7?Hz,?0.77H),?4.61?(d,?J?=?8.2?Hz,?0.27H),?4.03?–?3.19?(m,?14H).?IR?(KBr)?n:?3411,?2936,?2840,?1600,?1577,?1512,?1445,?1260,?1031,?759.。
In other proximate embodiment, also can adopt 1,3,4; 6-O-tetrabenzyl-N-(4-aminomethyl phenyl)-D-glucosamine, 1,3,4,6-O-tetrabenzyl-N-(4-chloro-phenyl-)-D-glucosamine, 1; 3,4,6-O-tetrabenzyl-N-(4-ethoxy acyl group phenyl)-D-glucosamine, 1,3; 4,6-O-tetrabenzyl-N-(3-methoxy acyl group phenyl)-D-glucosamine substitutes above-mentioned 1,3; 4,6-O-tetrabenzyl-N-phenyl-D-glucosamine carries out debenzylation, makes corresponding N-aryl-D-glucosamine.

Claims (8)

1. the compound method of a N-aryl-D-glucosamine comprises following steps:
Figure 201210059071X100001DEST_PATH_IMAGE001
S1. with formula ( α) shown in 1,3,4,6-O-tetrabenzyl-D-glucosamine hydrochloride, formula ( β) shown in aryl iodide, cesium carbonate, cuprous salt and 2-acetyl cyclohexanone be dissolved among the DMF, in 120-130 ℃ of following stirring reaction 8-20 hour, postcooling was accomplished in reaction under protection of nitrogen gas; The ether dilution is filtered, and takes out and desolvates; The silica gel chromatography dilution obtains intermediate product, formula ( γ) shown in 1,3,4,6-O-tetrabenzyl-N-aryl-D-glucosamine;
S2. the intermediate product that step S1 is obtained, formula ( γ) shown in 1,3,4,6-O-tetrabenzyl-N-aryl-D-glucosamine is dissolved in methyl alcohol and the ETHYLE ACETATE mixed solvent, adds trichoroacetic acid(TCA) and palladium carbon, feeding H 2, stirred 30-48 hour down in 40 ℃, filter, methanol wash is taken out and is desolvated, silica gel chromatography, finally obtain formula ( δ) shown in N-aryl-D-glucosamine.
2. the compound method of N-aryl-D-glucosamine according to claim 1 is characterized in that, said R is 3 or 4-substituting group, and substituting group is H, alkyl, alkoxyl group, halogen, COOR 1, R wherein 1Be alkyl.
3. the compound method of N-aryl-D-glucosamine according to claim 1 is characterized in that, among the said step S1, αThe consumption molar ratio of (1,3,4,6-O-tetrabenzyl-D-glucosamine hydrochloride) and aryl iodide be n ( α): n (aryl iodide)=1.0: 2.0 – 1.0: 3.0.
4. the compound method of N-aryl-D-glucosamine according to claim 1 is characterized in that, among the said step S1, cuprous salt is CuI, CuBr, CuCl; αThe consumption molar ratio of (1,3,4,6-O-tetrabenzyl-D-glucosamine hydrochloride) and cuprous salt be n ( α): n (cuprous salt)=1.0: 0.1 – 1.0: 0.2.
5. the compound method of N-aryl-D-glucosamine according to claim 1 is characterized in that, among the said step S1, αThe consumption molar ratio of (1,3,4,6-O-tetrabenzyl-D-glucosamine hydrochloride) and 2-acetyl cyclohexanone be n ( α): n (2-acetyl pimelinketone)=1.0: 0.2 – 1.0: 0.4.
6. the compound method of N-aryl-D-glucosamine according to claim 1 is characterized in that, among the said step S1, formula ( α) shown in 1,3,4, the consumption molar ratio of 6-O-tetrabenzyl-D-glucosamine hydrochloride and cesium carbonate is 1.0: 2.5 – 1.0: 3.0.
7. the compound method of N-aryl-D-glucosamine according to claim 1 is characterized in that, among the said step S1, αThe usage ratio of (1,3,4,6-O-tetrabenzyl-D-glucosamine hydrochloride) and solvent be n ( α): V (solvent)=1.0mmol: 0.5mL – 1.0mmol: 0.6mL.
8. the compound method of N-aryl-D-glucosamine according to claim 1 is characterized in that, among the said step S2, and intermediate product βWith the trichoroacetic acid(TCA) molar ratio be n ( β): n (trichoroacetic acid(TCA))=1.0: 1.0 – 1.0: 1.1.
CN201210059071XA 2012-03-08 2012-03-08 Synthetic method of N-aryl-D-glucosamine Pending CN102838639A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210059071XA CN102838639A (en) 2012-03-08 2012-03-08 Synthetic method of N-aryl-D-glucosamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210059071XA CN102838639A (en) 2012-03-08 2012-03-08 Synthetic method of N-aryl-D-glucosamine

Publications (1)

Publication Number Publication Date
CN102838639A true CN102838639A (en) 2012-12-26

Family

ID=47366391

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210059071XA Pending CN102838639A (en) 2012-03-08 2012-03-08 Synthetic method of N-aryl-D-glucosamine

Country Status (1)

Country Link
CN (1) CN102838639A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104961781A (en) * 2015-06-04 2015-10-07 淮海工学院 2-deoxy-2-isorhodanate-1,3,4,6-tetra-O-benzyl-beta-D-glucopyranose, and synthetic method and application thereof
CN110407830A (en) * 2019-08-21 2019-11-05 河南师范大学 A method of synthesis N- aryl phenothiazine compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5758368A (en) * 1980-09-26 1982-04-08 Fujitsu Ltd Photo electro potentiometer
JPS5758368B2 (en) * 1978-12-29 1982-12-09 Matsushita Electric Works Ltd
CN1775791A (en) * 2005-12-06 2006-05-24 浙江金壳生物化学有限公司 New method for preparing 2-deoxy-D-glucose

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5758368B2 (en) * 1978-12-29 1982-12-09 Matsushita Electric Works Ltd
JPS5758368A (en) * 1980-09-26 1982-04-08 Fujitsu Ltd Photo electro potentiometer
CN1775791A (en) * 2005-12-06 2006-05-24 浙江金壳生物化学有限公司 New method for preparing 2-deoxy-D-glucose

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DEREK HORTON: "The Anomeric 1,3,4,6-Tetra-O-acetyl-2-deoxy-2-(2,3-dinitroanilino)-D-glucopyranoses", 《THE JOURNAL OF ORGANIC CHEMISTRY》 *
胡帅帅,等: "碘化亚酮/乙二胺催化氮杂环化合物的N-芳基化反应", 《应用化学》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104961781A (en) * 2015-06-04 2015-10-07 淮海工学院 2-deoxy-2-isorhodanate-1,3,4,6-tetra-O-benzyl-beta-D-glucopyranose, and synthetic method and application thereof
CN104961781B (en) * 2015-06-04 2017-12-08 淮海工学院 The O benzyls β D glucopyranoses of 2 deoxidation, 2 isothiocyanates 1,3,4,6 4 and synthetic method and purposes
CN110407830A (en) * 2019-08-21 2019-11-05 河南师范大学 A method of synthesis N- aryl phenothiazine compound

Similar Documents

Publication Publication Date Title
CN109503572B (en) Method for synthesizing indole quinoline compounds
CN113307778A (en) Preparation method of 3-trifluoromethyl substituted 1,2, 4-triazole compound
CN102838639A (en) Synthetic method of N-aryl-D-glucosamine
CN111393384B (en) Application of cuprous complex containing ortho-carborane Schiff base ligand
CN105646382A (en) Preparation method of 1,3,5-trisubstituted 1,2,4-triazole compound
CN109265409B (en) Synthesis method of 2-substituted benzoxazole, 2-substituted benzothiazole and derivatives thereof
CN113072470B (en) N-acetonitrile bis-benzenesulfonylimine derivative and preparation method and application thereof
CN101462988A (en) Technique for synthesizing bicalutamide
CN108586350A (en) A kind of preparation method of imidazoles -2- thioketones
KR101653532B1 (en) Synthesis of Benzimidazoles bearing borionic acid functionality via metal-free aerobic oxidation
CN105153048B (en) A kind of preparation method of 2,4 quinazoline diones class compound
CN110698431B (en) Synthetic method of 1, 2-benzothiazine compound
CN113121401B (en) N-substituted carbonyl fluorosulfonamide compound, preparation method and application thereof
CN109265403B (en) Synthesis method of benzimidazole and derivatives thereof
CN106349182B (en) The preparation method of bis- substitutions of 4,5--thiazolamine compound
CN103214394B (en) A kind of Alkynyl imine derivative
CN100491387C (en) Ferrocenyl imidazoliny palladium compound, its preparation method and its uses in catalytic synthesis of coupling product
CN115385836B (en) Synthesis method of amino selenate compound
CN109867633B (en) Method for synthesizing 1,2, 3-triazole from beta-bromostyrene
CN110746336B (en) Green preparation method of N-methyl-2-cyano-3-arylpyrrole compound
CN113024475B (en) Synthetic method of quinoxalinone compound
CN110372718B (en) Difluoromethane thiochromanonthiophene compound and preparation method thereof
CN117327047A (en) Amide ligand and copper-catalyzed synthesis method of aminothiophene compound
CN116924940A (en) Synthesis method of o-iodo-aniline derivative
JPH1133407A (en) Asymmetric zirconium catalyst

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121226